title: Synthesis and contractile activities of cyclic thrombin receptor-derived peptide analogues with a Phe-Leu-Leu-Arg motif: importance of the Phe/Arg relative conformation and the primary amino group for activity.
abstract: Based on the minimal peptide sequence (Phe-Leu-Leu-Arg) that has been found to exhibit biological activity in a gastric smooth muscle contractile assay for thrombin receptor-activating peptides, the cyclic peptide analogues cyclo(Phe-Leu-Leu-Arg-Acp) (1), cyclo(Phe-Leu-Leu-Arg-epsilon Lys) (2), and cyclo(Phe-Leu-Leu-Arg-Gly) (3) have been synthesized by the solid-phase method using benzotriazol-1-yloxytris(dimethylamino)phosphonium hexafluoroborate or 2-(1H-benzo-triazol-1-yl)-1,1,3,3-tetramethyluronium tetrafluoroborate as cyclization reagents. The contractile activities of compounds 1-3 have been compared with that of the linear thrombin receptor-activating peptide (TRAP) Ser-Phe-Leu-Leu-Arg-NH2 (compound 4) using a gastric smooth muscle strip assay. Compound 2, wherein the epsilon-amino group of lysine was coupled to the alpha-carboxyl of arginine, exhibited a contractile activity comparable to that of the linear TRAP, compound 4. However compound 1, wherein the aminocaproic linker group yielded a ring size the same as for compound 2 but without a primary amino group, exhibited a contractile activity 600-1000-fold lower than compounds 2 and 4. Compound 3, which exhibited partial agonist activity, was about 100-fold less potent than either compound 2 or 4. NMR spectroscopy of compound 2 revealed a proximity of the Phe and Arg side chains, leading to a molecular model generated by distance geometry and molecular dynamics, wherein the Phe and Arg residues are shown in proximity on the same side of the peptide ring. We conclude that the Phe and Arg side chains along with the primary amino group form an active recognition motif that is augmented by the presence of a primary amino group in the cyclic peptide. We suggest that a comparable cyclic conformation may be responsible for the interaction of linear TRAPs with the thrombin receptor.
authors.affiliation: Department of Chemistry, University of Patras, Greece.
authors.forename: J M
authors.initials: JM
authors.lastname: Matsoukas
authors.forename: D
authors.initials: D
authors.lastname: Panagiotopoulos
authors.forename: M
authors.initials: M
authors.lastname: Keramida
authors.forename: T
authors.initials: T
authors.lastname: Mavromoustakos
authors.forename: R
authors.initials: R
authors.lastname: Yamdagni
authors.forename: Q
authors.initials: Q
authors.lastname: Wu
authors.forename: G J
authors.initials: GJ
authors.lastname: Moore
authors.forename: M
authors.initials: M
authors.lastname: Saifeddine
authors.forename: M D
authors.initials: MD
authors.lastname: Hollenberg
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D066298:In Vitro Techniques; D009682:Magnetic Resonance Spectroscopy; D008969:Molecular Sequence Data; D010456:Peptides, Cyclic / Q000138:chemical synthesis* / Q000737:chemistry / Q000494:pharmacology; D011487:Protein Conformation; D051381:Rats; D018179:Receptors, Thrombin / Q000187:drug effects*; D013270:Stomach / Q000187:drug effects* / Q000502:physiology; D013329:Structure-Activity Relationship
chemical_list: D010456:Peptides, Cyclic; D018179:Receptors, Thrombin